Description Mechanism of Action Biochem/physiol Actions Indications Overdosage References
ChemicalBook > CAS DataBase List > Fexofenadine hydrochloride

Fexofenadine hydrochloride

Description Mechanism of Action Biochem/physiol Actions Indications Overdosage References
Product Name
Fexofenadine hydrochloride
CAS No.
153439-40-8
Chemical Name
Fexofenadine hydrochloride
Synonyms
Fexo;Allegra;2-[4-[1-Hydroxy-4-[4-(hydroxy-diphenyl-methyl)-1-piperidyl]-butyl]phenyl]-2-methyl-propanoic acid hydrochloride;Telfast;Alernex;Feksine;Fexofen;Fexadyne;Vivafeks;Telfast BD
CBNumber
CB0256621
Molecular Formula
C32H40ClNO4
Formula Weight
538.13
MOL File
153439-40-8.mol
More
Less

Fexofenadine hydrochloride Property

Melting point:
148-150oC
RTECS 
CY1633377
storage temp. 
2-8°C
solubility 
Soluble in Dimethyl sulfoxide (50 mM), and methanol.
form 
powder
color 
white to beige
Merck 
14,4068
InChIKey
RRJFVPUCXDGFJB-UHFFFAOYSA-N
CAS DataBase Reference
153439-40-8(CAS DataBase Reference)
More
Less

Safety

Hazard Codes 
Xi
Risk Statements 
36/37/38
Safety Statements 
26-36
WGK Germany 
3
HS Code 
2933399090
More
Less

Hazard and Precautionary Statements (GHS)

Symbol(GHS)
Signal word
Warning
Hazard statements

H312Harmful in contact with skin

H317May cause an allergic skin reaction

H360May damage fertility or the unborn child

Precautionary statements

P261Avoid breathing dust/fume/gas/mist/vapours/spray.

P272Contaminated work clothing should not be allowed out of the workplace.

P280Wear protective gloves/protective clothing/eye protection/face protection.

P302+P352IF ON SKIN: wash with plenty of soap and water.

P312Call a POISON CENTER or doctor/physician if you feel unwell.

P321Specific treatment (see … on this label).

P322Specific measures (see …on this label).

P333+P313IF SKIN irritation or rash occurs: Get medical advice/attention.

P363Wash contaminated clothing before reuse.

P501Dispose of contents/container to..…

More
Less

N-Bromosuccinimide Price

Sigma-Aldrich
Product number
F9427
Product name
Fexofenadine hydrochloride
Purity
>98% (HPLC)
Packaging
10mg
Price
$187
Updated
2024/03/01
Sigma-Aldrich
Product number
1270377
Product name
Fexofenadine hydrochloride
Purity
United States Pharmacopeia (USP) Reference Standard
Packaging
200mg
Price
$436
Updated
2024/03/01
TCI Chemical
Product number
F0698
Product name
Fexofenadine Hydrochloride
Purity
>98.0%(HPLC)(T)
Packaging
1g
Price
$73
Updated
2024/03/01
TCI Chemical
Product number
F0698
Product name
Fexofenadine Hydrochloride
Purity
>98.0%(HPLC)(T)
Packaging
5g
Price
$200
Updated
2024/03/01
Alfa Aesar
Product number
J63262
Product name
Fexofenadine hydrochloride
Packaging
25mg
Price
$108.65
Updated
2024/03/01
More
Less

Fexofenadine hydrochloride Chemical Properties,Usage,Production

Description

Fexofenadine hydrochloride (trade name: Allegra) belongs to a second-generation antihistamine pharmaceutical drug. It is mainly used for the treatment of allergy symptoms including watery eyes, hay fever, nasal congestion, urticaria, runny nose, itching eyes/nose, sneezing, hives, and itching. It is a kind of selectively peripheral H1 blocker. Its mechanism of action in vivo is through preventing the histamine-mediated activation of the H1 receptors, thus alleviating the symptoms related to allergy. Compared to the first-generation antihistamine drug, it is less prone to penetrate the blood-brain barrier, reducing the possibility to cause side effects such as drowsiness.

Mechanism of Action

Fexofenadine hydrochloride is an antihistamine with selective peripheral H1-receptor antagonist activity. Both enantiomers of fexofenadine hydrochloride displayed approximately equipotent antihistaminic effects. Fexofenadine inhibited histamine release from peritoneal mast cells in rats. In laboratory animals, no anticholinergic, alpha1-adrenergic or beta-adrenergic-receptor blocking effects were observed. No sedative or other central nervous system effects were observed. Radiolabeled tissue distribution studies in rats indicated that fexofenadine does not cross the blood-brain barrier.

Biochem/physiol Actions

Fexofenadine is used in treating allergic rhinitis and chronic idiopathic urticaria. It may give relief in bothersome symptom and is a second-generation antihistamines. Fexofenadine provides better relief compared to other antihistamines for nasal congestion. It is the active metabolite of terfenadine and bring down allergen-induced symptoms.
Fexofenadine is a non-sedating H1 histamine receptor antagonist.

Indications

Seasonal Allergic Rhinitis
Fexofenadine hydrochloride(ALLEGRA) is indicated for the relief of symptoms associated with seasonal allergic rhinitis in adults and children 6 years of age and older. Symptoms treated effectively were sneezing, rhinorrhea, itchy nose/palate/throat, itchy/watery/red eyes.
Chronic Idiopathic Urticaria
ALLEGRA is indicated for treatment of uncomplicated skin manifestations of chronic idiopathic urticaria in adults and children 6 years of age and older. It significantly reduces pruritus and the number of wheals.
CONTRAINDICATIONS
ALLEGRA is contraindicated in patients with known hypersensitivity to any of its ingredients.

Overdosage

Reports of fexofenadine hydrochloride overdose have been infrequent and contain limited information. However, dizziness, drowsiness, and dry mouth have been reported. Single doses of fexofenadine hydrochloride up to 800 mg (six normal volunteers at this dose level), and doses up to 690 mg twice daily for 1 month (three normal volunteers at this dose level) or 240 mg once daily for 1 year (234 normal volunteers at this dose level) were administered without the development of clinically significant adverse events as compared to placebo.
In the event of overdose, consider standard measures to remove any unabsorbed drug. Symptomatic and supportive treatment is recommended.
Hemodialysis did not effectively remove fexofenadine hydrochloride from blood (1.7% removed) following terfenadine administration.
No deaths occurred at oral doses of fexofenadine hydrochloride up to 5000 mg/kg in mice (110 times the maximum recommended daily oral dose in adults and 200 times the maximum recommended daily oral dose in children based on mg/m2 ) and up to 5000 mg/kg in rats (230 times the maximum recommended daily oral dose in adults and 400 times the maximum recommended daily oral dose in children based on mg/m2 ). Additionally, no clinical signs of toxicity or gross pathological findings were observed. In dogs, no evidence of toxicity was observed at oral doses up to 2000 mg/kg (300 times the maximum recommended daily oral dose in adults and 530 times the maximum recommended daily oral dose in children based on mg/m2 ).

References

http://www.rxlist.com/allegra-drug/consumer-uses.htm
https://en.wikipedia.org/wiki/Fexofenadine

Description

Fexofenadine is a histamine H1 receptor antagonist (Ki = 10 nM). It reverses contraction of isolated rat tracheal strips induced by acetyl-β-methylcholine . Fexofenadine inhibits expression of IL-8 in TNF-α-stimulated HCT116 and COLO 205 cells. Oral administration of fexofenadine (2 and 10 mg/kg) reduces severity of colitis and phospho-IκB kinase activation in a mouse model of colitis induced by dextran sulfate sodium (DSS; ).

Chemical Properties

Off-White Crystalline Solid

Originator

Alernex,Dabur Pharmaceuticals Ltd.,India

Uses

Fexofenadine hydrochloride is used as an antihistamine that inhibits Cox-1, Cox-2, and is a histamine H1 receptor agonist.

Uses

A metabolite of of terfenadine, a H1-Histamine receptor antagonist

Uses

The active metabolite of Terfenadine (T114500), a H1-histamine receptor antagonist.

Uses

Fexofenadine is a non-sedating antihistamine that selectively antagonizes the histamine H1 receptor with a Ki value of 10 nM and exhibits anti-inflammatory effects. It is devoid of central nervous system effects in part because it is a good substrate for the P-glycoprotein efflux pump situated within the blood-brain barrier.[Cayman Chemical]

Uses

Antihistaminic;histamine H1-receptor antagonist

Definition

ChEBI: Fexofenadine hydrochloride is a diarylmethane.

Manufacturing Process

Microbiological Preparation of Fexofenadine (Patent U.S. 6,558,931)
Ten 250 ml Erlenmeyer flasks containing 100 ml of medium D are seeded with A. corymbifera LCP 63-1800. 50 mg of Terfenadine in 1 ml of ethanol is added to each Erlenmeyer flask. The content of 10 Erlenmeyer flasks are filtered on gauze (the supernatant has a pH equal to 8.0), and saturation with sodium chloride is carried out for 2 hours (pH = 5-6), followed by extracting 3 times with ethyl acetate and drying over magnesium sulfate. After evaporation under reduced pressure, 409 mg of expected crude product is obtained (yield = 77%, approximately 90% pure product). This product is purified on a column of silica gel (230-400 mesh, 40 g of silica, diameter = 3 cm) eluting with a methylene chloride/methanol/ammonium hydroxide mixture (82.5:15:2.5). 312 mg of pure Fexofenadine is recovered (61.4%).
Synthesis of Fexofenadine (Patent U.S. No. 5,578,610
Aluminum chloride (44 g; 0.33 mol) was added in portions to a solution of freshly distilled 4-chlorobutyryl chloride (17 mL; 0.15 mol) in 460 mL of carbon disulfide at -10°C under a nitrogen atmosphere. The mixture was stirred for 15 min, then the cooling bath was removed and the mixture was allowed to warm to ambient temperature. The mixture was stirred then for 15 min more, then cooled again to -10°C and a solution of ethyl-α,α- dimethylphenyl acetate (26.6 g; 0.14 mol) in 70 mL of carbon disulfide was added dropwise. The mixture was stirred for 3 hours, then stirred overnight at room temperature. The reaction mixture was partitioned between water and CHCl3. The combined organic portions were dried over MgSO4, filtered and concentrated in vacuo. The residue was dissolved in CH2Cl2 and filtered through a plug of SiO2, eluting with 10% EtOAc in hexane. Yield of ethyl 3- and 4-(4-chloro-1-oxobutyl)-α,α-dimethylphenylacetate 39.4 g (as a mixture of aromatic regioisomers).
To a solution of 39.4 g of ethyl 3- and 4-(4-chloro-1-oxobutyl)-α,α- dimethylphenylacetate dissolved in 800 mL of methanol and 200 mL of water was added 40 g of NaOH. The mixture was refluxed for one hour. The cooled mixture was then concentrated in vacuo. The concentrate was diluted with water and washed with 2 portions of EtOAc. The aqueous layer was acidified with concentrated HCl and extracted with 2 portions of EtOAc. The extracts were dried over MgSO4, filtered, and concentrated in vacuo to afford 30.3 g of crude product. The crude product was dissolved in 600 mL of EtOAc, 38 g of cinchonidine was added, and the mixture was stirred overnight. The resulting solids were filtered and washed with EtOAc and sucked dry under a rubber dam to afford 25 g of a solid 4-(cyclopropyl-oxo-methyl)-α,α- dimethylphenylacetic acid.
A solution of 10.5 g of 4-(cyclopropyl-oxo-methyl)-α,α-dimethylphenylacetic acid in 250 mL of CH2Cl2 was cooled in an ice-MeOH bath and 25 g of trimethylsilyliodide was then added via pipette. The mixture was stirred in the ice bath for one hour, warmed to ambient temperature, and stirred for one hour. A solution of aqueous sodium bisulfite was then added and the mixture was stirred well. The phases were partitioned and the aqueous layer was extracted with CH2Cl2. The combined organics were washed with saturated aqueous NaCl, dried over MgSO4, filtered, and concentrated in vacuo to afford 12.6 g (77%) of 4-(4-iodo-1-oxobutyl)-α,α-dimethylphenylacetic acid.
To a solution of 12.6 g of 4-(4-iodo-1-oxobutyl)-α,α-dimethylphenylacetic acid in 100 mL of ether cooled in an ice bath, was added 40 mL of ethereal CH2N2. The mixture was stirred at 0°C for few minutes, then let stand for 2 hours. A few drops of AcOH were added to decompose excess CH2N2, then the mixture was filtered and stripped to afford 12.6 g (96%) of methyl 4-(4-iodo-1- oxobutyl)-α,α-dimethylphenylacetate.
A solution of 12.6 g of methyl 4-(4-iodo-1-oxobutyl)-α,α- dimethylphenylacetate in 500 mL of toluene in a one liter three neck flask was added 8.8 g of 4-(α,α-diphenyl)piperidinemethanol and 23 g of K2CO3 and the mixture was refluxed for 7 hours. The cooled reaction mixture was then filtered and concentrated in vacuo. The residue was dissolved in ether and treated with excess ethereal HCl. The mixture was then concentrated to a solid. The solid was treated with EtOAc and collected by filtration. The product was then partitioned between EtOAc and 2 N Na2CO3. The organics were dried over MgSO4, filtered, and concentrated in vacuo to afford 13.5 g (79%) of methyl 4-[4-[4-(hydroxydiphenylmethyl)-1-piperidinyl]-1-oxobutyl]-α,α- dimethylphenylacetate.
A solution of 13.5 g of methyl 4-[4-[4-(hydroxydiphenylmethyl)-1-piperidinyl]- 1-oxobutyl]-α,α-dimethylphenylacetate in 250 mL of methanol was cooled in an ice-methanol bath and 1.8 g of NaBH4 was added in portions. After 1 hour, the mixture was concentrated to a solid. The residue was partitioned between EtOAc and saturated aqueous NaHCO3. The aqueous portion was extracted with EtOAc. The combined organics were washed with saturated aqueous NaCl, dried over MgSO4, filtered, and concentrated in vacuo to afford 9.5 g (70%) of methyl 4-[4-[4-(hydroxydiphenylmethyl)-1-piperidinyl]-1- hydroxybutyl]-α,α-dimethylphenylacetate as a foam.
To a solution of 9.5 g of methyl-4-[4-[4-(hydroxydiphenylmethyl)-1- piperidinyl]-1-hydroxybutyl]-α,α-dimethylphenylacetate in 300 mL of methanol and 150 mL of water was added 10 g of NaOH. The mixture was refluxed for 1 hour, then cooled. The methanol was removed in vacuo. The concentrate was diluted with water and CHCl3 and the pH adjusted to approximately 5.5 to 6.0. The phases were separated and the aqueous phase was extracted with CHCl3. The combined organics were dried over MgSO4, filtered, and stripped to afford 9.0 g of crude product. The crude product was dissolved in CH2Cl2 and chromatographed on Davisil Grade 633 SiO2 eluting with a gradient of CHCl3, to 10% of methanol in CHCl3, to 25% of methanol in CHCl3. The product was concentrated to afford 5.2 g of white crystals of 4-[4-[4- (hydroxydiphenylmethyl)-1-piperidinyl]-1-hydroxybutyl]-α,α-dimethylphenylacetic acid (Fexofenadine).
In practice it is usually used as hydrochloride salt.

Therapeutic Function

Antihistaminic

General Description

Fexofenadine hydrochloride, (±)-4-[1-hydroxy-4-[4-(hydroxyldiphenylmethyl)- 1-piperinyl]butyl-α,α-dimethylbenzeneacetic acid (Allegra), occurs as a white to off-white crystalline powder that is freely soluble in methanol and ethanol, slightly soluble in chloroform and water, and insoluble in hexane.
This compound is marketed as a racemate and exists as a zwitterion in aqueous media at physiological pH. Fexofenadine is a primary oxidative metabolite of terfenadine. Terfenadine was developed during a search for new butyrophenone antipsychotic drugs as evidenced by the presence of the N-phenylbutanol substituent. It also contains a diphenylmethyl-piperidine moiety analogous to that found in the piperazine antihistamines.

Biological Activity

Fexofenadine hydrochloride is a selective histamine H1 receptor antagonist (pKi = 8.1). Active metabolite of Terfenadine that displays non-sedating antiallergic effects. Fexofenadine hydrochloride counteracts histamine mediated immune suppression and improves immunotherapy response.

Biochem/physiol Actions

Fexofenadine is a non-sedating H1 histamine receptor antagonist.

Clinical Use

Antihistamine:
Symptomatic relief of rhinitis and urticaria

Drug interactions

Potentially hazardous interactions with other drugs
Antibacterials: effects possibly reduced by rifampicin.
Antivirals: concentration possibly increased by ritonavir.
Aluminium/magnesium containing antacids: reduced absorption - avoid for 2 hours.

Metabolism

Fexofenadine undergoes negligible metabolism (hepatic or non-hepatic); about 5% of the total dose is metabolised, mostly by the intestinal mucosa, with 0.5-1.5% of the dose undergoing hepatic biotransformation by the cytochrome P450 system. The major route of elimination is believed to be via biliary excretion while up to 10% of ingested dose is excreted unchanged through the urine.

Fexofenadine hydrochloride Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

Fexofenadine hydrochloride Suppliers

Sichuan Xuhui Pharmaceutical Co., Ltd.
Tel
0838-5106555
Fax
NULL
Email
2870731454@qq.com
Country
China
ProdList
4
Advantage
58
Wuhan DingCheng Biochemical Co.Ltd
Tel
027-81302558 13545255233
Email
2851686513@qq.com
Country
China
ProdList
842
Advantage
58
J & K SCIENTIFIC LTD.
Tel
010-82848833 400-666-7788
Fax
86-10-82849933
Email
jkinfo@jkchemical.com
Country
China
ProdList
96815
Advantage
76
Meryer (Shanghai) Chemical Technology Co., Ltd.
Tel
4006608290; 18621169109
Fax
86-21-61259102
Email
market03@meryer.com
Country
China
ProdList
40241
Advantage
62
3B Pharmachem (Wuhan) International Co.,Ltd.
Tel
821-50328103-801 18930552037
Fax
86-21-50328109
Email
3bsc@sina.com
Country
China
ProdList
15848
Advantage
69
future industrial shanghai co., ltd
Tel
400-0066400 13621662912
Fax
021-55660885
Email
sales@jonln.com
Country
China
ProdList
1998
Advantage
65
TCI (Shanghai) Development Co., Ltd.
Tel
021-67121386
Fax
021-67121385
Email
Sales-CN@TCIchemicals.com
Country
China
ProdList
24539
Advantage
81
Energy Chemical
Tel
021-021-58432009 400-005-6266
Fax
021-58436166
Email
sales8178@energy-chemical.com
Country
China
ProdList
44751
Advantage
61
Adamas Reagent, Ltd.
Tel
400-6009262 16621234537
Fax
021-64823266
Email
zhangsn@titansci.com
Country
China
ProdList
14113
Advantage
59
ShengXiong Biological Technology Development Co., Ltd.
Tel
86-021-64960112 13774219177
Fax
86-021-64960112
Email
alpha9196@gmail.com
Country
China
ProdList
52
Advantage
65
Shanghai Longsheng chemical Co.,Ltd.
Tel
021-58099652-8005 13585536065
Fax
021-58099609
Email
bin.wu@shlschem.com
Country
China
ProdList
9816
Advantage
59
Shanghai Hanhong Scientific Co.,Ltd.
Tel
021-54306202 13764082696;
Email
info@hanhongsci.com
Country
China
ProdList
42982
Advantage
64
Chemsky(shanghai)International Co.,Ltd.
Tel
021-50135380
Email
shchemsky@sina.com
Country
China
ProdList
32344
Advantage
50
XiaoGan ShenYuan ChemPharm co,ltd
Tel
0712-0712-2580635 15527768850
Email
1791901229@qq.com
Country
China
ProdList
8849
Advantage
52
Zhejiang Qiming Pharmaceutical Co., Ltd.
Tel
+86-571-87163895 +86-571-87163893
Fax
+86-571-87163816
Email
sales@qimingpharm.com
Country
China
ProdList
87
Advantage
65
Shanghai Sunway Pharmaceutical Technology Co., Ltd
Tel
+8618575662672 18575662672
Fax
021 51613951
Email
mzeng@3wpharm.com
Country
China
ProdList
9747
Advantage
57
Spectrum Chemical Manufacturing Corp.
Tel
021-021-021-67601398-809-809-809 15221380277
Fax
021-57711696
Email
marketing_china@spectrumchemical.com
Country
China
ProdList
9664
Advantage
60
Wuhan Fortuna Chemical Co., Ltd
Tel
027-027-59207852 13308628970
Fax
QQ3130921841
Email
buy@fortunachem.com
Country
China
ProdList
2893
Advantage
58
Dalian Meilun Biotech Co., Ltd.
Tel
0411-62910999 13889544652
Email
sales@meilune.com
Country
China
ProdList
4647
Advantage
58
BioBioPha Co., Ltd.
Tel
0871-65217109 13211707573;
Fax
0871-65215563
Email
y.liu@mail.biobiopha.com
Country
China
ProdList
5654
Advantage
65
Chengdu Ai Keda Chemical Technology Co., Ltd.
Tel
4008-755-333 18080918076
Fax
028-86757656
Email
800078821@qq.com
Country
China
ProdList
9725
Advantage
55
S.Z. PhyStandard Bio-Tech. Co., Ltd.
Tel
0755-4000505016 13380397412
Fax
0755 28094224
Email
3001272453@qq.com
Country
China
ProdList
4974
Advantage
50
S.Z. PhyStandard Bio-Tech. Co., Ltd.
Tel
0755-83725681-603
Fax
+86 755 28094224
Country
China
ProdList
4505
Advantage
50
Beijing HuaMeiHuLiBiological Chemical
Tel
010-56205725
Fax
010-65763397
Email
waley188@sohu.com
Country
China
ProdList
12338
Advantage
58
Shanghai T&W Pharmaceutical Co., Ltd.
Tel
+86 21 61551611
Fax
+86 21 50676805
Country
China
ProdList
9901
Advantage
58
Haoyuan Chemexpress Co., Ltd.
Tel
021-58950125
Fax
(86) 21-58955996
Email
info@chemexpress.com
Country
China
ProdList
7553
Advantage
61
9ding chemical ( Shanghai) Limited
Tel
4009209199
Fax
86-021-52271987
Email
sales@9dingchem.com
Country
China
ProdList
22519
Advantage
55
Shanghai Aladdin Bio-Chem Technology Co.,LTD
Tel
18521735133 18521732826;
Fax
021-50323701
Email
market@aladdin-e.com
Country
China
ProdList
25015
Advantage
65
The future of Shanghai Industrial Co., Ltd.
Tel
021-61552785
Fax
021-55660885
Email
sales@shshiji.com
Country
China
ProdList
9552
Advantage
55
Hunan Furui Biopharma Technology Co., Ltd.
Tel
15902102743
Fax
0731-57805668
Email
shelley@furuipharma.com
Country
China
ProdList
435
Advantage
55
Nanjing Sunlida Biological Technology Co., Ltd.
Tel
025-57798810
Fax
025-57019371
Email
sales@sunlidabio.com
Country
China
ProdList
3750
Advantage
55
TargetMol Chemicals Inc.
Tel
021-33632979 15002134094
Fax
021-33632979
Email
marketing@targetmol.com
Country
China
ProdList
7934
Advantage
58
Jinan Mingya Medical Technology Co., Ltd.
Tel
0531-85828981
Fax
+86-531-85806006
Email
864598798@qq.com
Country
China
ProdList
588
Advantage
58
Wuhan DKY Technology Co.,Ltd.
Tel
27-81302488 18007166089
Fax
027-81302088
Email
info@dkybpc.com
Country
China
ProdList
2024
Advantage
58
Hubei XinyuanShun Chemical Co., Ltd.
Tel
13971561712, 13995564702, 027-50664929
Fax
027-50664927
Email
hbeixys2001@163.com
Country
China
ProdList
3123
Advantage
55
Shanghai Meishui Chemical Technology Co., Ltd
Tel
021-60549325 18616193163
Fax
021-33250306
Country
China
ProdList
4528
Advantage
56
Shanghai JONLN Reagent Co., Ltd.
Tel
400-0066400 13621662912
Fax
021-55660885
Email
422131432@qq.com
Country
China
ProdList
9986
Advantage
55
Shanghai Worldyang Chemical Co.,Ltd.
Tel
021-021-56795766
Fax
+86-21-56795266
Email
sales@worldyachem.com
Country
China
ProdList
9352
Advantage
58
ChemStrong Scientific Co.,Ltd
Tel
0755-0755-66853366 13670046396
Fax
0755-28363542
Email
sales@chem-strong.com
Country
China
ProdList
17982
Advantage
56
Chengdu HuaXia Chemical Reagent Co. Ltd
Tel
400-1166-196 13458535857
Fax
QQ:800101999
Email
cdhxsj@163.com
Country
China
ProdList
13358
Advantage
58
Wuxi Zhongkun Biochemical Technology Co., Ltd.
Tel
0510-85629785 18013409632
Fax
051085625359
Email
sales@reading-chemicals.com
Country
China
ProdList
15185
Advantage
58
Finetech Industry Limited
Tel
027-87465837 19945049750
Fax
027-8777-2287
Email
sales@finetechnology-ind.com
Country
China
ProdList
9636
Advantage
58
Wuhan Dahua Pharmaceutical Co., Ltd.
Tel
027-59262863 13277907145 3091977954
Fax
027-59420980
Country
China
ProdList
4951
Advantage
58
Shanghai YuLue Chemical Co., Ltd.
Tel
021-60345187 13671753212
Fax
021-34702061
Email
lzz841106@aliyun.com
Country
China
ProdList
10287
Advantage
55
Shanghai Kewel Chemical Co., Ltd.
Tel
021-64609169 18901607656
Fax
021-64609160
Email
greensnown@163.com
Country
China
ProdList
9911
Advantage
50
Hangzhou J&H Chemical Co., Ltd.
Tel
+86-571-87396432
Fax
0571-87396431
Email
sales@jhechem.com
Country
China
ProdList
10015
Advantage
53
Wuhan Dahua Weiye Pharmaceutical Chemical Co., Ltd.
Tel
027-59420981,18702770802
Fax
027-83322098
Country
China
ProdList
1975
Advantage
50
AdooQ Bioscience CHINA
Tel
025-58849295 18951903616;
Fax
025-68650336
Email
info@adooq.cn
Country
China
ProdList
2989
Advantage
60
Credit Asia Chemical Co., Ltd.
Tel
+86 (21) 61124340
Fax
+86 (21) 6129-4103
Country
China
ProdList
9767
Advantage
58
Cool Pharm, Ltd
Tel
021-60455363 18019463053
Fax
50966098
Email
sales@coolpharm.com
Country
China
ProdList
12357
Advantage
58
More
Less

View Lastest Price from Fexofenadine hydrochloride manufacturers

Hebei Dangtong Import and export Co LTD
Product
Fexofenadine hydrochloride 153439-40-8
Price
US $320.00-315.00/kg
Min. Order
10kg
Purity
99.99%
Supply Ability
100Tons
Release date
2023-03-17
Ouhuang Engineering Materials (Hubei) Co., Ltd
Product
Fexofenadine hydrochloride 153439-40-8
Price
US $15.00/kg
Min. Order
1kg
Purity
99.912%
Supply Ability
10ton
Release date
2024-04-28
PNP Biotech Co. Ltd
Product
Fexofenadine Hydrochloride 153439-40-8
Price
US $0.00/kg
Min. Order
25kg
Purity
98%
Supply Ability
Inquiry
Release date
2022-10-31

153439-40-8, Fexofenadine hydrochloride Related Search:


  • α,α-dimethyl-4-[1-hydroxy-4-[4-(hydroxydiphenylmethyl)-1-piperidinyl]butyl]benzeneacetic acid
  • Benzeneacetic acid, 4-[1-hydroxy-4-[4-(hydroxydiphenylmethyl)-1-piperidinyl]butyl]-α,α-dimethyl-, hydrochloride
  • MDL 16455A
  • Telfast
  • Telfast BD
  • 2-[4-[1-Hydroxy-4-[4-(hydroxy-diphenyl-methyl)-1-piperidyl]-butyl]phenyl]-2-methyl-propanoic acid hydrochloride
  • Allegra
  • Fexofenadine hydrochloride
  • 2-[4-[1-hydroxy-4-[4-[hydroxy(diphenyl)methyl]-1-piperidyl]butyl]phenyl]-2-methyl-propionic acid hydrochloride
  • FERULICACIDPIPERAZINE
  • (Carboxyterfenadine-D10,Terfenadinecarboxylate)
  • Fexofenidine hydrochloride, MDL 16455 hydrochloride, Terfenidine carboxylate hydrochloride
  • (138452-21-8) fexofenadine hydrochloride
  • 2-[4-[1-hydroxy-4-[4-[hydroxy(diphenyl)methyl]piperidin-1-yl]butyl]phenyl]-2-methylpropanoic acid hydrochloride
  • 2-[4-[1-hydroxy-4-[4-[hydroxy(diphenyl)methyl]piperidin-1-yl]butyl]phenyl]-2-methyl-propanoic acid hydrochloride
  • Fexofenadine(Hclform)
  • α,α-Dimethyl-4-[1-hydroxy-4-[4-(hydroxydiphenylmethyl)-1-piperidinyl]butyl]-benzeneaceticacidhydrochloride
  • Fexofenadine hydrochloride,Fexofenidine hydrochloride, MDL 16455 hydrochloride, Terfenidine carboxylate hydrochloride
  • 2-{4-[(1R)-1-hydroxy-4-[4-(hydroxydiphenylMethyl)piperidin-1-yl]butyl]phenyl}-2-Methylpropanoic acid
  • 4-[1-Hydroxy-4-[4-(hydroxydiphenylMethyl)-1-piperidinyl]butyl]-α,α-diMethylbenzeneacetic Acid Hydrochloride
  • Alernex
  • Carboxyterfenadine Hydrochloride
  • Feksine
  • Fexadyne
  • Fexo
  • Fexofen
  • Terfenadinecarboxylate Hydrochloride
  • Vivafeks
  • (R)-2-(4-(1-hydroxy-4-(4-(hydroxydiphenylMethyl)piperidin-1-yl)butyl)phenyl)-2-Methylpropanoic acid hydrochloride
  • 2-(4-(1-Hydroxy-4-(4-(hydroxydiphenylmethyl)piperidin-1-yl)butyl)phenyl)-2-methylpropanoic acid h
  • Benzeneaceticacid, 4-[1-hydroxy-4-[4-(hydroxydiphenylMethyl)-1-piperidinyl]butyl]-a,a-diMethyl-,hydrochloride (1:1)
  • feofenadine hydrochloride
  • 2-(4-(1-Hydroxy-4-(4-(hydroxydiphenylmethyl)piperidin-1-yl)butyl)phenyl)-2-methylpropanoic aci
  • FEXOFENADINE-D10 HCL
  • Non - Determination of hydrochloride
  • FexofenadineHydrochloride&gt
  • Fexofenadine Hydrochloride RS
  • Fexofenadine hydrochloride CRS
  • Fexofenadine hydrochloride b
  • Fexofenadine hydrochloride Fexofenadine hcl
  • Fexofenadine hydrochloride USP/EP/BP
  • Fexofenadine hydrochloride salt
  • Fexofenadine Hydrochloride (Y000789)Q: What is Fexofenadine Hydrochloride (Y000789) Q: What is the CAS Number of Fexofenadine Hydrochloride (Y000789)
  • Fexofenadine HydrochlorideQ: What is Fexofenadine Hydrochloride Q: What is the CAS Number of Fexofenadine Hydrochloride Q: What is the storage condition of Fexofenadine Hydrochloride Q: What are the applications of Fexofenadine Hydrochloride
  • 153439-40-8 Fexofenadine hydrochloride
  • Fexofenadine Hydrochloride (1270377)
  • Fexofenadine Hydrochloride IP/USP/Ph. Eur/BP
  • Fexofenadine Hydrochloride IP/BP/USP/EP
  • Fexofenadine Hydrochloride, ≥ 98.0%
  • 153439-40-8
  • C32H29D10NO4HCl
  • C32H39NO4ClH
  • C32H39NO4xHCl
  • C32H40ClNO4
  • C32H39ClNO4
  • API
  • Aromatics
  • Heterocycles